Studies showed that IFN-γ is a key molecule acting against tumor microenvironments because it can inhibit angiogenesis and cellular proliferation, promote apoptosis in cancer cells, and activate the immune system by antigen presentation [49,50]. This evidence concerns the gene IFNG and cancer.